Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about SOMAÃ Pharmaceuticals
Recent news which mentions SOMAÍ Pharmaceuticals
Most Important Medical Potential Of Marijuana? Cannabis For Pain Relief Says Biotech CEO
December 21, 2023
Tags
Market News
Cannabis
Michael Sassano
From
Benzinga
Euro Weed: Netherlands Kicks Off Legal Cannabis Sales, 2 Swiss Pilot Projects Underway & More
December 14, 2023
Tags
Deputy Marc Leadbeater
Market News
Cann/L
From
Benzinga
SOMAÍ To Enter Polish Medical Cannabis Market Via Cosma
June 12, 2023
Tags
SOMAÍ Pharmaceuticals
Cosma Cannabis
News
From
Benzinga
Clever Leaves Teams Up With SOMAÍ Pharma., Completes First CBD Extract Shipments To Portugal
May 25, 2023
Tickers
CLVR
CLVRW
Tags
Andres Fajardo
News
SOMAÍ Pharmaceuticals
From
Benzinga
Vertical Integration: Cannabis Experts Discuss Its Various Pros And Cons
July 22, 2022
Tags
The Pantheon Collective
Government
M&A
From
Benzinga
Disposable Vapes Are An Environmental Concern But Producers Won't Stop Making 'til You Stop Buying
July 18, 2022
Tags
Benzinga
Market News
shopping
From
Benzinga
Switzerland Removes Medical Marijuana Access Limitations As Demand Rises
June 23, 2022
Tickers
JAZZ
Tags
Switzerland medical marijauana
SOMAÍ Pharmaceuticals
News
From
Benzinga
Cannabis Insiders Split On Market Impact Of Inflation
June 16, 2022
Tickers
CGC
KERN
Tags
Benzinga
Penny Stocks
Cannabis
From
Benzinga
Which Countries Will Likely Legalize Cannabis In 2022 And Why Isn't The U.S. Among Them?
December 23, 2021
Tags
Dave Joyce
Pelorus Fund
Benzinga
From
Benzinga
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So.
July 29, 2021
Tickers
COST
CVS
GWPH
HRVSF
Tags
Regulations
News
SOMAÍ Pharmaceuticals
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.